---
schema_version: "secwatch.filing_event.v1"
accession: "0001093557-24-000020"
form_type: "8-K"
ticker: "DXCM"
cik: "0001093557"
company_name: "DEXCOM INC"
filed_at: "2024-02-08T23:59:59+00:00"
generated_at: "2026-06-06T05:18:23.065282+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Dexcom Q4 2023 revenue $1.03B, up 27%; GAAP EPS $0.62; FY2024 guidance $4.15-4.35B

## Summary
- Q4 2023 revenue $1.03B (+27% YoY); GAAP operating income $216.9M (21.0% margin).
- GAAP net income $256.3M ($0.62 diluted EPS) vs $91.8M ($0.22) in Q4 2022.
- Full-year 2023 revenue $3.62B (+24% YoY); GAAP operating margin 16.5% (+310 bps).
- 2024 guidance: revenue $4.15-4.35B (16-21% organic growth); non-GAAP op margin ~20%.
- Submitted Stelo glucose sensor for type 2 diabetes (non-insulin) and direct-to-watch feature to FDA.

## SEC filing metadata
- accession: 0001093557-24-000020
- form_type: 8-K
- ticker: DXCM
- cik: 0001093557
- company_name: DEXCOM INC
- filed_at: 2024-02-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1093557/000109355724000020/0001093557-24-000020-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1093557/000109355724000020/dxcm-20240208.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001093557-24-000020
- JSON: https://secwatch.observer/filing/0001093557-24-000020.json
- Plain text: https://secwatch.observer/filing/0001093557-24-000020.txt

## Key facts
- Earnings Releases
  DEXCOM INC updated its the quarter and year ended December 31, 2023 guidance (reaffirmed).
  - Period: the quarter and year ended December 31, 2023
  - Guidance: reaffirmed
  - Result: reported results
  source text: On February 8, 2024, DexCom, Inc. (“Dexcom”) issued a press release announcing its financial results for the quarter and year ended December 31, 2023 and certain other information.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1093557/000109355724000020/0001093557-24-000020-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.